Acetyl Tetrapeptide-5 is a synthetic cosmetic tetrapeptide primarily developed for periorbital skincare, especially products targeting the appearance of under-eye puffiness, eye bags, dark circles, dehydration, and loss of elasticity.

It is commonly associated with the trade name EYESERYL®. Chemically, it is N-acetyl-β-alanyl-L-histidyl-L-seryl-L-histidine, with the peptide sequence:

Ac-β-Ala-His-Ser-His-OH

Its reported cosmetic activity includes modulation of processes associated with fluid accumulation, vascular permeability, skin hydration, and glycation.

Importantly, most evidence for its cosmetic benefits comes from supplier/manufacturer studies and formulation research, rather than large, independently replicated clinical trials. Therefore, claims should be interpreted as cosmetic efficacy rather than established drug-level treatment of eye bags or dark circles.

1. Origin and Production

Acetyl Tetrapeptide-5 is synthetically produced, rather than extracted from animal tissue or plants.

A typical peptide manufacturing strategy is solid-phase peptide synthesis (SPPS), in which protected amino acids are sequentially assembled on a solid support, followed by cleavage, deprotection, purification, and quality control. Commercial ingredient documentation describes Acetyl Tetrapeptide-5 as a synthetic peptide.

The final material may be purified using chromatographic techniques such as high-performance liquid chromatography (HPLC).

For commercial raw materials, important quality parameters include:

• HPLC purity

• peptide identity

• residual solvents

• water content

• heavy metals

• microbial contamination

• peptide degradation products

• batch-to-batch consistency

2. Structural Characteristics

Acetyl Tetrapeptide-5 consists of four amino-acid residues:

Acetyl-β-alanine → Histidine → Serine → Histidine

The N-terminal acetyl group modifies the peptide’s chemical properties and contributes to its stability compared with an unmodified peptide.

The presence of histidine residues gives the molecule imidazole-containing side chains, while serine contributes a hydroxyl group. These functional groups can participate in hydrogen bonding and influence interactions with biological targets.

Its relatively small molecular size—approximately 492.5 Da—is advantageous for cosmetic peptide formulation, although molecular weight alone does not guarantee efficient penetration through the stratum corneum.

3. Why Is It Used Around the Eyes?

The periorbital region has several characteristics that make it particularly susceptible to visible changes:

• relatively thin skin

• high visibility of underlying vessels

• tendency toward fluid accumulation

• frequent mechanical movement

• reduced structural support with aging

• susceptibility to dehydration

• relatively delicate extracellular matrix

Consequently, even relatively small changes in hydration or interstitial fluid can noticeably affect the appearance of the eye area.

Acetyl Tetrapeptide-5 is therefore formulated primarily in eye creams, eye gels, eye serums, and other periorbital products.

4. Main Cosmetic Benefits

4.1 Reduction of the appearance of eye puffiness

This is arguably its most characteristic application.

Acetyl Tetrapeptide-5 is intended to reduce the appearance of fluid-related under-eye swelling and produce a less tired-looking eye contour.

It is particularly relevant when puffiness is associated with:

• transient fluid retention

• morning swelling

• Fatigue

• mild periorbital edema

It is less likely to dramatically change a structurally prominent fat pad or genetically determined anatomical eye bag.

4.2 Improvement in the appearance of eye bags

By addressing fluid accumulation and improving the appearance of the surrounding skin, it may make eye bags appear less pronounced.

This distinction is important:

Cosmetic peptide ≠ surgical correction of structural eye bags.

If the underlying problem is orbital fat protrusion or significant tissue laxity, topical Acetyl Tetrapeptide-5 is unlikely to reproduce the effects of blepharoplasty.

4.3 Improvement of dark-circle appearance

Acetyl Tetrapeptide-5 is often marketed for dark circles.

However, dark circles have multiple causes, including:

• vascular visibility

• Pigmentation

• shadowing from anatomical hollows

• thin skin

• Dehydration

• Inflammation

• aging

Therefore, a peptide that improves hydration or puffiness may improve some types of dark-circle appearance but will not necessarily correct pigmentation or structural tear-trough shadows.

4.4 Hydration

Acetyl Tetrapeptide-5 is classified in cosmetic ingredient databases as having humectant/moisturizing functions.

Improved hydration can temporarily make fine lines look less prominent and give the eye area a smoother appearance.

4.5 Skin elasticity and firmness

Some studies and reviews associate Acetyl Tetrapeptide-5 with improvements in the appearance of elasticity and firmness around the eyes.

The effect is likely to be subtle compared with procedures that physically tighten or remodel tissue.

5. How to Use It in Skincare

For a finished cosmetic product containing Acetyl Tetrapeptide-5:

Morning

• Cleanse.

• Apply eye serum/cream containing the peptide.

• Apply moisturizer if needed.

• Finish with sunscreen.

Evening

• Cleanse.

• Apply the eye product.

• Follow with moisturizer if desired.

Apply a small amount around the orbital area rather than directly onto the eyelid margin or into the eye.

Consistency is more important than applying a large amount.

6. What Results Should Be Expected?

A realistic expectation is gradual improvement in the appearance of the eye contour, particularly when puffiness and dehydration are important contributors.

Potentially noticeable effects include:

• less visibly puffy under-eyes

• smoother-looking skin

• improved hydration

• somewhat less pronounced fine lines

• improved appearance of tired-looking eyes

It should not be expected to:

• permanently remove eye bags

• eliminate genetic dark circles

• replace blepharoplasty

• dramatically correct deep tear troughs

• permanently tighten severely lax skin

7. Overall Assessment

Category	Assessment
Primary purpose	Periorbital cosmetic care
Best-known benefit	Reduction in appearance of puffiness
Secondary benefits	Hydration, smoother appearance, elasticity, dark-circle appearance
Mechanism	Proposed ACE modulation, vascular-permeability/fluid effects, anti-glycation and antioxidant-related activity
Scientific evidence	Promising but limited
Independent clinical evidence	Relatively limited
Formulation compatibility	Generally favorable
Typical use	Eye creams, gels and serums
Safety	Generally well tolerated topically
Best suited for	Mild/moderate appearance of puffiness and early periorbital aging
Poor candidate for	Major anatomical eye bags or deep structural tear troughs

Conclusion

Acetyl Tetrapeptide-5 is a specialized cosmetic tetrapeptide with its strongest positioning in eye-area skincare. Its principal proposed effect is to reduce the appearance of periorbital puffiness, supported by mechanisms involving ACE modulation, vascular permeability/fluid dynamics, and potentially anti-glycation and antioxidant effects.

Its major strength is that it addresses several visible aspects of the aging eye contour—puffiness, hydration, elasticity and fine-line appearance—within a single low-use-level peptide active. However, the scientific literature is still relatively limited, and much of the frequently cited efficacy data originates from manufacturer-sponsored testing.

Consequently, Acetyl Tetrapeptide-5 is best regarded as a promising cosmetic active for improving the appearance of tired, puffy and aging eye contours, rather than as a clinically proven treatment capable of eliminating anatomical eye bags or all forms of dark circles.